BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 33407381)

  • 1. Can a nomogram predict apical prostate cancer pathology upgrade from fusion biopsy to final pathology? A multicenter study.
    Feng T; Liang Z; Xiao Y; Pan B; Zhou Y; Ma C; Zhou Z; Yan W; Zhu M
    Cancer Med; 2024 Jun; 13(11):e7341. PubMed ID: 38845479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Difference between prostate cancer patients' Gleason scores from preoperative biopsy and those from postoperative pathology].
    Zhao XD; Liu YH; Hu J; Wang ZH; Jin XX; Ma MF; Zhou YL; Chen YH; Cao J; Dong J; Xu S
    Zhonghua Nan Ke Xue; 2023 May; 29(5):393-401. PubMed ID: 38602754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a microultrasound-based nomogram to predict extra-prostatic extension in patients with prostate cancer undergoing robot-assisted radical prostatectomy.
    Frego N; Contieri R; Fasulo V; Maffei D; Avolio PP; Arena P; Beatrici E; Sordelli F; De Carne F; Lazzeri M; Saita A; Hurle R; Buffi NM; Casale P; Lughezzani G
    Urol Oncol; 2024 May; 42(5):159.e9-159.e16. PubMed ID: 38423852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer.
    Miyoshi Y; Noguchi K; Yanagisawa M; Taguri M; Morita S; Ikeda I; Fujinami K; Miura T; Kobayashi K; Uemura H
    BMC Cancer; 2015 May; 15():338. PubMed ID: 25929438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Suppression of the Epithelial to Mesenchymal Transition in Prostate Cancer through the Targeting of MYO6 Using MiR-145-5p.
    Armstrong L; Willoughby CE; McKenna DJ
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Performance of Different Parametric Ultrasounds in Prostate Cancer Diagnosis: Correlation with Radical Prostatectomy Specimens.
    Jawli A; Nabi G; Huang Z
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparing Data for Artificial Intelligence in Pathology with Clinical-Grade Performance.
    Yang Y; Sun K; Gao Y; Wang K; Yu G
    Diagnostics (Basel); 2023 Oct; 13(19):. PubMed ID: 37835858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Health Index (
    Yan JQ; Huang D; Huang JY; Ruan XH; Lin XL; Fang ZJ; Gao Y; Jiang HW; Wu YS; Na R; Xu DF
    Asian J Androl; 2022; 24(4):406-410. PubMed ID: 34782549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer in 2010: GSU: misclassification or biological progression?
    Capitanio U; Suardi N
    Nat Rev Urol; 2011 Feb; 8(2):65-6. PubMed ID: 21304540
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting Gleason sum upgrading from biopsy to radical prostatectomy pathology: a new nomogram and its internal validation.
    Wang X; Zhang Y; Zhang F; Ji Z; Yang P; Tian Y
    BMC Urol; 2021 Jan; 21(1):3. PubMed ID: 33407381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined multiple clinical characteristics for prediction of discordance in grade and stage in prostate cancer patients undergoing systematic biopsy and radical prostatectomy.
    Liu H; Tang K; Xia D; Peng E; Wang L; Chen Z
    Pathol Res Pract; 2020 Nov; 216(11):153235. PubMed ID: 33035728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gleason sum upgrading between biopsy and radical prostatectomy in Chinese population: Updated nomograms.
    Xu H; Bai PD; Hu MB; Mao SH; Zhu WH; Hu JM; Liu SH; Yang T; Hou JY; Hu Y; Ding Q; Jiang HW
    Actas Urol Esp; 2017 Apr; 41(3):162-171. PubMed ID: 27522521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation.
    He B; Chen R; Gao X; Ren S; Yang B; Hou J; Wang L; Yang Q; Zhou T; Zhao L; Xu C; Sun Y
    Oncotarget; 2016 Mar; 7(13):17275-85. PubMed ID: 26943768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI-RADS v2 and periprostatic fat measured on multiparametric magnetic resonance imaging can predict upgrading in radical prostatectomy pathology amongst patients with biopsy Gleason score 3 + 3 prostate cancer.
    Zhai L; Fan Y; Sun S; Wang H; Meng Y; Hu S; Wang X; Yu W; Jin J
    Scand J Urol; 2018; 52(5-6):333-339. PubMed ID: 30895901
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.